INFANRIX PENTA

Swiss trademark · 486658 · Word mark · Deleted

Register entry

Registration number
486658
Application number
00113/2001
Status
Deleted
Type
Word mark
Filed
Jan 5, 2001
Registered
Jul 4, 2001
Published
Aug 10, 2001
Deleted
Jul 28, 2021
Reason
Not renewed
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmaceutical and medical preparations and substances; Vaccines

As filed

Pharmazeutische und medizinische Präparate und Substanzen; Impfstoffe.

Translated automatically. Only the text as filed is legally binding.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 28, 2021

    Deleted, not renewed

    Published in Swissreg on 28.07.2021

  2. Apr 16, 2014

    Agent’s address changed

    Representative
    A. W. Metz & Co. AG, Hottingerstrasse 14, 8024 Zürich → A.W. Metz & Co. AG, Kreuzbühlstrasse 8, 8008 Zürich

    Published in Swissreg on 16.04.2014

  3. Dec 29, 2010

    Renewed

    Published in Swissreg on 29.12.2010

  4. Mar 22, 2010

    Agent entered

    Representative
    BOHEST AG, Postfach 160, 4003 Basel → A. W. Metz & Co. AG, Hottingerstrasse 14, 8024 Zürich

    Published in Swissreg on 22.03.2010

  5. May 5, 2008

    Agent’s address changed

    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel → BOHEST AG, Postfach 160, 4003 Basel

    Published in the SOGC no. 85 of 05.05.2008

  6. May 26, 2003

    Holder’s address changed

    Owner
    SmithKline Beecham Biologicals S.A., 89, Rue de l'Institut, 1330 Rixensart, Belgium → GlaxoSmithKline Biologicals S.A., Rue de l'Institut 89, 1330 Rixensart, Belgium

    Published in the SOGC no. 99 of 26.05.2003

  7. Aug 10, 2001

    Registered

    Published in the SOGC no. 153 of 10.08.2001

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.